(Q35805726)

10 August 2017

Multidrug-resistant tuberculosis management in resource-limited settings (English)

1 reference

multidrug-resistant tuberculosis

10 August 2017

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

1 reference

20

Mario C Raviglione

1 reference

10 August 2017

8

J Peter Cegielski

1 reference

10 August 2017

1

Eva Nathanson

1 reference

10 August 2017

12

Ernesto Jaramillo

1 reference

10 August 2017

Catharina Lambregts-van Weezenbeek

2

1 reference

10 August 2017

Michael L Rich

3

1 reference

10 August 2017

Rajesh Gupta

4

1 reference

10 August 2017

Jaime Bayona

5

1 reference

10 August 2017

Kai Blöndal

6

1 reference

10 August 2017

José A Caminero

7

1 reference

10 August 2017

Manfred Danilovits

9

1 reference

10 August 2017

Marcos A Espinal

10

1 reference

10 August 2017

Vahur Hollo

11

1 reference

10 August 2017

Vaira Leimane

13

1 reference

10 August 2017

Carole D Mitnick

14

1 reference

10 August 2017

Joia S Mukherjee

15

1 reference

10 August 2017

Paul Nunn

16

1 reference

10 August 2017

Alexander Pasechnikov

17

1 reference

10 August 2017

Thelma Tupasi

18

1 reference

10 August 2017

Charles Wells

19

1 reference

10 August 2017

1 September 2006

1 reference

Emerging Infectious Diseases

10 August 2017

1 reference

10 August 2017

12

1 reference

10 August 2017

9

1 reference

10 August 2017

1389-1397

1 reference

Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: a cohort study in the Philippines

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

Global incidence of multidrug-resistant tuberculosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

Results of a standardised regimen for multidrug-resistant tuberculosis in Bangladesh.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

Programmes and principles in treatment of multidrug-resistant tuberculosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

WHO, the Global Fund, and medical malpractice in malaria treatment

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

Increasing transparency in partnerships for health--introducing the Green Light Committee

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

WHO's new Stop TB Strategy.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

Community-based approaches to HIV treatment in resource-poor settings

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

Improved outcomes for patients with multidrug-resistant tuberculosis.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294733

First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17073088

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

PUBLIC HEALTH: Responding to Market Failures in Tuberculosis Control

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17073088

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3201/EID1209.051618

1 reference

10 August 2017

1 reference

10 August 2017

1 reference